Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
Hospital Authority, Hong Kong
CD30+ Peripheral T-cell Lymphoma
1 trial -
Insulin
The First People's Hospital of Lianyungang
Gestational Diabetes
1 trial -
Ipilimumab
Iovance Biotherapeutics B.V.
Metastatic Melanoma
1 trial -
Irinotecan Hydrochloride Liposome Injection๏ผCarboplatin Injection๏ผSerplulimab Injection
The First People's Hospital of Lianyungang
Small Cell Lung Cancer
1 trial -
Ivarmacitinib tablet
The First People's Hospital of Lianyungang
Polymyalgia Rheumatics (PMR)
1 trial -
Ixekizumab+Jueyin Granules
Universal Integrated
Plaque Psoriasis
1 trial -
Kunxian capsule
The First People's Hospital of Lianyungang
Diabetic Nephropathy
1 trial -
Leuprorelin acetate + Sintilimab
The First People's Hospital of Lianyungang
NSCLC, Stage III
1 trial -
Levetiracetam (Keppra)
United Therapeutics Europe Ltd
Alcohol Abuse
1 trial -
Lidocaine Hydrochloride, Injectable
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Liver Cancer
1 trial -
Low potassium content vegetables
Xiyuan Hospital of China Academy of Chinese Medical Sciences
End-stage Renal Disease
1 trial -
Low-fat milk group
BRIGHT MINDS BIOSCIENCES INC.
Metabolic Syndrome
1 trial -
Lubiprostone
Takeda
Constipation-predominant Irritable Bowel Syndrome
1 trial -
Lubiprostone
Takeda
Diabetes Mellitus, Type 1
1 trial -
Maternal Nutritional Supplement
Abbott Australasia Pty Ltd
Breast Feeding
1 trial -
Metformin hydrochloride sustained release tablets
The First People's Hospital of Lianyungang
Osteoarthritis
1 trial -
Methylphenidate HCl ER tablets 1
BRIGHT MINDS BIOSCIENCES INC.
Attention Deficit Hyperactivity Disorder
1 trial -
Modafinil Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
Nab-paclitaxel
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Nicotine Replacement Therapy (Habitrol)
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Nicotine Replacement Treatment (NRT)
BRIGHT MINDS BIOSCIENCES INC.
Substance Abuse
1 trial -
Nitazoxanide Tablets
Vera Therapeutics
COVID-19
1 trial -
Nut group
BRIGHT MINDS BIOSCIENCES INC.
Metabolic Syndrome
1 trial -
Obinutuzumab
The First People's Hospital of Lianyungang
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources